Literature DB >> 15687890

JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways.

Yaron Niv1, Ajay Goel, C Richard Boland.   

Abstract

PURPOSE OF REVIEW: Most colorectal cancers (CRCs) have deletions, duplications, and rearrangements of their chromosomes that reflect a destabilizing process called chromosomal instability (CIN). The cause of CIN is controversial, but no intrinsic mutation in cancer cells has been reported that can reasonably account for this in CRC. This review explores the new hypothesis that JC virus (JCV) may be the cause of CIN. RECENT
FINDINGS: A polyomavirus has been found in most colon cancers that encodes a T-antigen gene, which can induce CIN in several laboratory models. This virus, JCV, infects virtually every human population that has been investigated, and evidence for the virus has been found in the gastrointestinal tracts of most healthy adults. It is hypothesized that the virus infects the gut in childhood and remains there in a latent form for most people. In people who develop colorectal neoplasia, it is proposed that the virus is activated, and expression of the oncogene-T-antigen-leads to CIN. This form of genomic instability is necessary to explain the losses of tumor suppressor genes that occur in the context of the multistep carcinogenesis pathway. Furthermore, it is proposed that once neoplastic colonic epithelial cells have experienced biallelic inactivation of a critical number of tissue-specific tumor suppressor genes-including APC and p53-the ongoing effect of the transforming virus may be relatively deleterious to a neoplastic cell, and selective pressure may lead to loss of viral infection.
SUMMARY: This review summarizes the experimental data that have led to the hypothesis that JCV is a common cause of CIN in CRC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687890

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  26 in total

1.  Presence of JC virus DNA in the tumor tissue and normal mucosa of patients with sporadic colorectal cancer (CRC) or with positive family history and Bethesda criteria.

Authors:  Alex Vilkin; Ziv Ronen; Zohar Levi; Sara Morgenstern; Marisa Halpern; Yaron Niv
Journal:  Dig Dis Sci       Date:  2011-08-10       Impact factor: 3.199

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 3.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 4.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 5.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

6.  John Cunningham virus T-antigen expression in anal carcinoma.

Authors:  Sonia Ramamoorthy; Bikash Devaraj; Katsumi Miyai; Linda Luo; Yu-Tsueng Liu; C Richard Boland; Ajay Goel; John M Carethers
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

Review 7.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 8.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

9.  Genetic and epigenetic characteristics of gastric cancers with JC virus T-antigen.

Authors:  Satoshi Yamaoka; Hiroyuki Yamamoto; Katsuhiko Nosho; Hiroaki Taniguchi; Yasushi Adachi; Shigeru Sasaki; Yoshiaki Arimura; Kohzoh Imai; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

10.  Natalizumab in the treatment of Crohn's disease.

Authors:  Danila Guagnozzi; Renzo Caprilli
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.